323 related articles for article (PubMed ID: 12388594)
21. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
McGee AW; Strittmatter SM
Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
[TBL] [Abstract][Full Text] [Related]
22. TACE-induced cleavage of NgR and p75NTR in dorsal root ganglion cultures disinhibits outgrowth and promotes branching of neurites in the presence of inhibitory CNS myelin.
Ahmed Z; Mazibrada G; Seabright RJ; Dent RG; Berry M; Logan A
FASEB J; 2006 Sep; 20(11):1939-41. PubMed ID: 16849393
[TBL] [Abstract][Full Text] [Related]
23. [Inhibitory proteins against axon regeneration in the central nervous system].
Hu JG; Lu PH; Xu XM
Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
[TBL] [Abstract][Full Text] [Related]
24. Nogo on the go.
McKerracher L; Winton MJ
Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839
[TBL] [Abstract][Full Text] [Related]
25. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
[TBL] [Abstract][Full Text] [Related]
26. Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor.
Walmsley AR; McCombie G; Neumann U; Marcellin D; Hillenbrand R; Mir AK; Frentzel S
J Cell Sci; 2004 Sep; 117(Pt 19):4591-602. PubMed ID: 15331667
[TBL] [Abstract][Full Text] [Related]
27. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
[TBL] [Abstract][Full Text] [Related]
28. Identification of a functional epitope of the Nogo receptor by a combinatorial approach using ribosome display.
Schimmele B; Plückthun A
J Mol Biol; 2005 Sep; 352(1):229-41. PubMed ID: 16061255
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C
Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405
[TBL] [Abstract][Full Text] [Related]
30. Rational design, solution conformation and identification of functional residues of the soluble and structured Nogo-54, which mimics Nogo-66 in inhibiting the CNS neurite outgrowth.
Li M; Li Y; Liao X; Liu J; Qin H; Xiao ZC; Song J
Biochem Biophys Res Commun; 2008 Sep; 373(4):498-503. PubMed ID: 18585367
[TBL] [Abstract][Full Text] [Related]
31. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration.
Ng CE; Tang BL
J Neurosci Res; 2002 Mar; 67(5):559-65. PubMed ID: 11891768
[TBL] [Abstract][Full Text] [Related]
32. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.
Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM
J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258
[TBL] [Abstract][Full Text] [Related]
33. Expression and function of myelin-associated proteins and their common receptor NgR on oligodendrocyte progenitor cells.
Huang JY; Wang YX; Gu WL; Fu SL; Li Y; Huang LD; Zhao Z; Hang Q; Zhu HQ; Lu PH
Brain Res; 2012 Feb; 1437():1-15. PubMed ID: 22227458
[TBL] [Abstract][Full Text] [Related]
34. The Nogo/Nogo Receptor (NgR) Signal Is Involved in Neuroinflammation through the Regulation of Microglial Inflammatory Activation.
Fang Y; Yan J; Li C; Zhou X; Yao L; Pang T; Yan M; Zhang L; Mao L; Liao H
J Biol Chem; 2015 Nov; 290(48):28901-14. PubMed ID: 26472924
[TBL] [Abstract][Full Text] [Related]
35. LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition.
Thomas R; Favell K; Morante-Redolat J; Pool M; Kent C; Wright M; Daignault K; Ferraro GB; Montcalm S; Durocher Y; Fournier A; Perez-Tur J; Barker PA
J Neurosci; 2010 May; 30(19):6607-12. PubMed ID: 20463223
[TBL] [Abstract][Full Text] [Related]
36. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
[TBL] [Abstract][Full Text] [Related]
37. Nogo and the Nogo-66 receptor.
Fournier AE; GrandPré T; Gould G; Wang X; Strittmatter SM
Prog Brain Res; 2002; 137():361-9. PubMed ID: 12440378
[TBL] [Abstract][Full Text] [Related]
38. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration.
Fournier AE; GrandPre T; Strittmatter SM
Nature; 2001 Jan; 409(6818):341-6. PubMed ID: 11201742
[TBL] [Abstract][Full Text] [Related]
39. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
Cao Y; Shumsky JS; Sabol MA; Kushner RA; Strittmatter S; Hamers FP; Lee DH; Rabacchi SA; Murray M
Neurorehabil Neural Repair; 2008; 22(3):262-78. PubMed ID: 18056009
[TBL] [Abstract][Full Text] [Related]
40. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact.
Wang X; Chun SJ; Treloar H; Vartanian T; Greer CA; Strittmatter SM
J Neurosci; 2002 Jul; 22(13):5505-15. PubMed ID: 12097502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
